Lung carcinomas decrease the number of monocytes/macrophages (CD14+ cells) that produce TNF-α

Clinical Immunology

Volumn 122, Issue 3, 2007, Pages 323-329

  Lopez Gonzalez, Jose Sullivan ^a   Avila Moreno, Federico ^a   Prado Garcia, Heriberto ^a   Aguilar Cazares, Dolores ^a   Mandoki, Juan Jose ^b   Meneses Flores, Manuel ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Lung cancer; M2 phenotype; Macrophages; Peripheral blood; Pleural effusion; Smoking and non smoking subjects; Tuberculosis; Tumor necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; LUNG CARCINOMA; MACROPHAGE; MALE; MONOCYTE; PLEURA EFFUSION; PRIORITY JOURNAL; TUBERCULOSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; CARCINOMA, SQUAMOUS CELL; CELL COMMUNICATION; CELL COUNT; COCULTURE TECHNIQUES; FEMALE; HUMANS; IMMUNOPHENOTYPING; LUNG NEOPLASMS; MACROPHAGES; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 33846867690     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.11.003     Document Type: Article

References (35)

1. Fujiwara N., and Kobayashi K. Macrophages in inflammation. Curr. Drug Targets Inflamm. Allergy 4 (2005) 281-286
2. Van Ginderachter J.A., Movahedi K., Hassanzadeh G.G., Meerschaut S., Beschin A., Raes G., and De Baetselier P. Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology 211 (2006) 487-501
3. Sica A., Schioppa T., Mantovani A., and Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42 (2006) 717-727
4. Sunderkotter C., Steinbrink K., Goebeler M., Bhardwaj R., and Sorg C. Macrophages and angiogenesis. J. Leukocyte Biol. 55 (1994) 410-422
5. Mantovani A., Sozzani S., Locati M., Allavena P., and Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23 (2002) 549-555
6. Szlosarek P., Charles K.A., and Balkwill F.R. Tumour necrosis factor-alpha as a tumour promoter. Eur. J. Cancer 42 (2006) 745-750
7. Lejeune F.J., Ruegg C., and Lienard D. Clinical applications of TNF-alpha in cancer. Curr. Opin. Immunol. 10 (1998) 573-580
8. Balkwill F. Tumor necrosis factor or tumor promoting factor?. Cytokine Growth Factor Rev. 13 (2002) 135-141
9. Karin M., and Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5 (2005) 749-759
10. Li Q., Withoff S., and Verma I.M. Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol. 26 (2005) 318-325
11. Hamed E.A., El Noweihi A.M., Mohamed A.Z., and Mahmoud A. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions. Respirology 9 (2004) 81-86
12. Odeh M., Sabo E., Srugo I., and Oliven A. Tumour necrosis factor alpha in the diagnostic assessment of pleural effusion. QJM 93 (2000) 819-824
13. Alexandrakis M.G., Coulocheri S.A., Bouros D., Mandalaki K., Karkavitsas N., and Eliopoulos G.D. Evaluation of inflammatory cytokines in malignant and benign pleural effusions. Oncol. Rep. 7 (2000) 1327-1332
14. Momi H., Matsuyama W., Inoue K., Kawabata M., Arimura K., Fukunaga H., and Osame M. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions. Respir. Med. 96 (2002) 817-822
15. Gursel G., Gokcora N., Elbeg S., Samurkasoglu B., and Ekim N. Tumor necrosis factor-alpha (TNF-alpha) in pleural fluids. Tuber. Lung Dis. 76 (1995) 370-371
16. Lopez-Gonzalez J.S., Hernandez G.A., Noyola M.I., Cazares D.A., Mandoki J.J., Morales F.M., Mendieta I.C., and Caloca J.V. Evasion mechanisms to tumor necrosis factor alpha (TNF-alpha) of small cell lung carcinoma and non-small cell lung carcinoma cell lines: comparison with the erythroleukaemia K-562 cell line. Lung Cancer 27 (2000) 177-187
17. Kreyberg L. Historical typing of lung tumors (1981) 1-36
18. Laan M., Qvarfordt I., Riise G.C., Andersson B.A., Larsson S., and Linden A. Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes. Thorax 54 (1999) 911-916
19. Skold C.M., Lundahl J., Hallden G., Hallgren M., and Eklund A. Chronic smoke exposure alters the phenotype pattern and the metabolic response in human alveolar macrophages. Clin. Exp. Immunol. 106 (1996) 108-113
20. Whiteside T.L., Miescher S., MacDonald H.R., Von F., and V. Separation of tumor-infiltrating lymphocytes from tumor cells in human solid tumors. A comparison between velocity sedimentation and discontinuous density gradients. J. Immunol. Methods 90 (1986) 221-233
21. Lopez-Gonzalez J.S., Aguilar-Cazares D., Prado-Garcia H., Nieto-Rodriguez A., Mandoki J.J., Avila-Moreno F., Rivera R.M., and Chavarría-Garcés J. Lack of correlation between growth inhibition by TGF-beta and the percentage of cells expressing type II TGF-beta receptor in human non-small cell lung carcinoma cell lines. Lung Cancer 38 (2002) 149-158
22. Hino M., Kohchi C., Nishizawa T., Yoshida A., Nakata K., Inagawa H., Hori H., Makino K., Terada H., and Soma G. Innate-immune therapy for lung carcinoma based on tissue-macrophage activation with lipopolysaccharide. Anticancer Res. 25 (2005) 3747-3754
23. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques 15 (1993) 532-537
24. Hodge S.J., Hodge G.L., Reynolds P.N., Scicchitano R., and Holmes M. Increased production of TGF-beta and apoptosis of T lymphocytes isolated from peripheral blood in COPD. Am. J. Physiol.: Lung Cell. Mol. Physiol. 285 (2003) L492-L499
25. Piemonti L., Monti P., Allavena P., Sironi M., Soldini L., Leone B.E., Socci C., Di C., and V. Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 162 (1999) 6473-6481
26. Avila-Moreno F., López-González J.S., Galindo-Rodriguez G., Prado-Garcia H., Bajaña S., and Sanchez-Torres C. Lung squamous cell carcinoma and adenocarcinoma cell lines use different mediators to induce comparable phenotypic and functional changes in human monocyte-derived dendritic cells. Cancer Immunol. Immunother. 55 (2006) 598-611
27. Atanackovic D., Block A., de Weerth A., Faltz C., Hossfeld D.K., and Hegewisch-Becker S. Characterization of effusion-infiltrating T cells: benign versus malignant effusions. Clin. Cancer Res. 10 (2004) 2600-2608
28. Chen Y.M., Yang W.K., Whang-Peng J., Tsai C.M., and Perng R.P. An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. Lung Cancer 31 (2001) 25-30
29. Gjomarkaj M., Pace E., Melis M., Spatafora M., and Toews G.B. Mononuclear cells in exudative malignant pleural effusions. Characterization of pleural phagocytic cells. Chest 106 (1994) 1042-1049
30. Antony V.B., Godbey S.W., Kunkel S.L., Hott J.W., Hartman D.L., Burdick M.D., and Strieter R.M. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J. Immunol. 151 (1993) 7216-7223
31. Kataki A., Scheid P., Piet M., Marie B., Martinet N., Martinet Y., and Vignaud J.M. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J. Lab. Clin. Med. 140 (2002) 320-328
32. Chang C.I., Liao J.C., and Kuo L. Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res. 61 (2001) 1100-1106
33. Allavena P., Signorelli M., Chieppa M., Erba E., Bianchi G., Marchesi F., Olimpio C.O., Bonardi C., Garbi A., Lissoni A., de Braud F., Jimeno J., and D'Incalci M. Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production. Cancer Res. 65 (2005) 2964-2971
34. Ortegel J.W., Staren E.D., Faber L.P., Warren W.H., and Braun D.P. Modulation of tumor-infiltrating lymphocyte cytolytic activity against human non-small cell lung cancer. Lung Cancer 36 (2002) 17-25
35. Shurin G.V., Yurkovetsky Z.R., and Shurin M.R. Tumor-induced dendritic cell dysfunction. In: Ochoa A.C. (Ed). Mechanisms of tumor escape from the immune response (2003), Taylor and Francis 112-138